Learn more →
Back to Expert Scholars
translational-research / translational-researchBreast Cancer Biology

Frédéric Piscuoglio

弗雷德里克·皮斯科格利奥

PhD

🏢University of Basel / University Hospital Basel(巴塞尔大学 / 巴塞尔大学医院)🌐Switzerland

Associate Professor, Department of Biomedicine, Cancer Biology Group生物医学系副教授,癌症生物学研究组

40
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Dr. Frédéric Piscuoglio is a leading cancer genomics researcher at the University of Basel. His work characterizing the molecular evolution of breast cancer and salivary gland tumors using whole-genome sequencing has revealed novel drivers and therapeutic targets in rare and common cancers.

Share:

🧪Research Fields 研究领域

Breast Cancer乳腺癌
Cancer Genomics肿瘤基因组学
Tumor Evolution肿瘤进化
Salivary Gland Tumors唾液腺肿瘤

🎓Key Contributions 主要贡献

Breast Cancer Genomic Landscape

Performed comprehensive whole-genome and transcriptome analyses of breast cancer subtypes, uncovering mutational signatures, structural variants, and clonal evolution patterns driving heterogeneity.

Salivary Gland Tumor Genomics

Characterized the genomic landscape of rare salivary gland carcinomas including adenoid cystic carcinoma, identifying MYB fusions and novel druggable alterations in these understudied tumors.

Tumor Heterogeneity and Evolution

Applied multi-region sequencing and single-cell approaches to map clonal evolution in breast cancer, linking genomic diversity to therapy resistance and metastatic potential.

Representative Works 代表性著作

[1]

Whole-genome sequencing of matched primary and metastatic breast cancers

Nature Genetics (2016)

Revealed somatic evolution during breast cancer metastasis, identifying late-arising driver mutations and clonal selection patterns relevant to treatment resistance.

[2]

Genomic landscape of adenoid cystic carcinoma of the breast

Journal of Pathology (2017)

First comprehensive genomic characterization of breast adenoid cystic carcinoma, establishing it as a MYB-NFIB-driven entity with distinct biology from conventional breast cancer.

[3]

Mutational landscape of metaplastic breast carcinoma

npj Breast Cancer (2019)

Identified PI3K pathway and Wnt signaling alterations in metaplastic breast carcinoma, providing the genomic rationale for targeted therapy trials in this chemoresistant subtype.

🏆Awards & Recognition 奖项与荣誉

🏆Swiss National Science Foundation Project Grant
🏆Krebsliga Schweiz Research Award
🏆European Breast Cancer Research Foundation Early Career Prize
🏆University of Basel Research Excellence Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 弗雷德里克·皮斯科格利奥 的研究动态

Follow Frédéric Piscuoglio's research updates

留下邮箱,当我们发布与 Frédéric Piscuoglio(University of Basel / University Hospital Basel)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment